Tag: Odyssey Therapeutics

Executive Change: Odyssey Therapeutics Appoints Jolie Siegel as Executive Vice President General Counsel

Executive Change: Odyssey Therapeutics Appoints Jolie Siegel as Executive Vice President General Counsel

Boston, MA – Odyssey Therapeutics has announced the appointment of Jolie Siegel as Executive Vice President, General Counsel. Odyssey Therapeutics is a biotechnology company dedicated to transforming the standard of care for patients suffering from…

Read More Read More

Cambridge Massachusetts based Odyssey Therapeutics is raising $168,000,000.00 in New Equity Investment.

Cambridge Massachusetts based Odyssey Therapeutics is raising $168,000,000.00 in New Equity Investment.

Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Odyssey Therapeutics is raising $168,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Gary Glick…

Read More Read More